Education
About Us
Working with TipRanks
Follow Us
Hims & Hers Health (DE:82W)
FRANKFURT:82W
82W Stock Chart & Stats
Day’s Range― - ―
52-Week Range€10.56 - €69.68
Previous CloseN/A
Volume1.67K
Average Volume (3M)2.45K
Market Cap
$8.08B
Enterprise Value€5.53B
Total Cash (Recent Filing)$220.58M
Total Debt (Recent Filing)$11.35M
Price to Earnings (P/E)72.5
Beta2.47
Next Earnings
May 05, 2025EPS Estimate
0.11Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.49
Shares Outstanding215,287,610
10 Day Avg. Volume2,740
30 Day Avg. Volume2,454
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap0.68
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.72
Enterprise Value/Ebitda75.85
Forecast
1Y Price Target
$36.87Price Target Upside3.48% Upside
Rating ConsensusHold
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Business ModelToday's announcement further validates HIMS' direct-to-consumer model as a platform for broader drug partnerships.
Market PositionHims & Hers Health, Inc. is uniquely positioned to personalize and democratize healthcare and wellness, making it a standout platform with scale and awareness.
PartnershipsToday's announced partnership with Novo Nordisk is an extremely important validation of the HIMS business model and also removes a significant amount of concerns on the path to maintaining weight management revenue.
Bears Say
Competitive LandscapeThe competitive landscape is intensifying, which poses challenges for Hims & Hers Health, Inc.
Consumer TrendsThe Underperform rating is reiterated due to weakening consumer trends and growth rates.
Financial ProjectionsThere are concerns that estimates for FY25 and FY26 will likely come down, presenting downside risk to the stock.
---
Options Prices
Currently, No data available
---
Ownership Overview
10.26% Insiders
16.28%
Mutual Funds
0.41% Other Institutional Investors
52.95% Public Companies and
Individual Investors
82W FAQ
What was Hims & Hers Health’s price range in the past 12 months?
Hims & Hers Health lowest stock price was €10.56 and its highest was €69.68 in the past 12 months.
What is Hims & Hers Health’s market cap?
Hims & Hers Health’s market cap is $8.08B.
When is Hims & Hers Health’s upcoming earnings report date?
Hims & Hers Health’s upcoming earnings report date is May 05, 2025 which is tomorrow.
How were Hims & Hers Health’s earnings last quarter?
Hims & Hers Health released its earnings results on Feb 24, 2025. The company reported €0.097 earnings per share for the quarter, missing the consensus estimate of €0.1 by -€0.003.
Is Hims & Hers Health overvalued?
According to Wall Street analysts Hims & Hers Health’s price is currently Undervalued.
Does Hims & Hers Health pay dividends?
Hims & Hers Health does not currently pay dividends.
What is Hims & Hers Health’s EPS estimate?
Hims & Hers Health’s EPS estimate is 0.11.
How many shares outstanding does Hims & Hers Health have?
Hims & Hers Health has 215,287,610 shares outstanding.
What happened to Hims & Hers Health’s price movement after its last earnings report?
Hims & Hers Health reported an EPS of €0.097 in its last earnings report, missing expectations of €0.1. Following the earnings report the stock price went down -20.832%.
Which hedge fund is a major shareholder of Hims & Hers Health?
Currently, no hedge funds are holding shares in DE:82W
---
Hims & Hers Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$36.87 (3.48% Upside)
$36.87 (3.48% Upside)
Blogger Sentiment
Bullish
DE:82W Sentiment 82%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $3.1M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 99%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
233.49%
12-Months-Change
Fundamentals
Return on Equity
30.71%
Trailing 12-Months
Asset Growth
64.29%
Trailing 12-Months
Company Description
Hims & Hers Health
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
---
82W Company Deck
---
82W Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong revenue and subscriber growth, along with strategic acquisitions and innovations in personalized treatment offerings. However, challenges such as declining gross margins, potential regulatory issues, and transitions in product offerings present notable risks. Overall, the positives in growth and strategic direction are tempered by these operational and regulatory concerns.Read More>---
82W Revenue Breakdown
96.60% Online
3.40% Wholesale
---
82W Stock 12 Month Forecast
Average Price Target
€36.87
▲(3.48% Upside)
Technical Analysis
---